Stay updated on Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.

Latest updates to the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer/version tag has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software release rather than a change to the clinical study record.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedThe page now displays a new Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded Revision: v3.4.2 to the site and removed the previous Revision: v3.4.1 along with the government funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedA site-wide funding notice banner was added, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov for updates. The page also shows a minor revision note: Revision: v3.4.1 replaces v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.